Work

Efficacy of alemtuzumab (ALZ) in combination with dose-adjusted EPOCH (DA-EPOCH) in untreated nodal peripheral T-cell lymphoma (PTCL).

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.8051

Authors: Cliona Grant, Kieron Dunleavy, John E. Janik, Margaret Shovlin, Seth M. Steinberg, Francesco D'Amore, Maryalice Stetler-Stevenson, Stefania Pittaluga, Elaine S. Jaffe, Wyndham Hopkins Wilson

Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2610340383

Cites:

Cited by:

Related to: 10